Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0160
-0.0005 (-3.03%)
Jul 17, 2026, 3:52 PM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 14.44 million as of July 17, 2026. Its market cap has decreased by -6.34% in one year.
Market Cap
14.44M
Enterprise Value
11.43M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 14.44M, a decrease of -93.40%. That is a compound annual growth rate of -35.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 14.44M | -50.49% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 43.98M |
| Compumedics | 43.95M |
| Nova Eye Medical | 34.18M |
| CleanSpace Holdings | 29.59M |
| Control Bionics | 28.43M |
| Memphasys | 24.70M |
| Micro-X | 24.68M |
| ImpediMed | 14.03M |